2023 annual financial data
Xeris Biopharma Holdings 2023 Operating margin
Direct answer
Operating margin was -26.85%.
Operating income was -44,010,000 USD and net income was -62,255,000 USD.
Operating cash flow was -47,023,000 USD.
Get free Xeris Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 163,914,000 USD
- Operating income
- -44,010,000 USD
- Net income
- -62,255,000 USD
- Operating cash flow
- -47,023,000 USD